Passage Bio, Inc. (PASG) has a market capitalization of $34.84M and trades at $10.86. The 52-week range is 5.124-20.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0.8, Earnings Per Share (EPS) of $-14.35.
The stock has a beta of 1.77, operates in the Healthcare sector.
